PMID: 303 LiuYKohlbergerTNorouziMDahlGESmithJLMohtashamianAet al
Semaglutide is a type of injectable GLP-1 medication
It stimulates two key metabolic receptors: GLP-1, like Wegovy GIP, which further enhances insulin control and weight-loss effects Because of this dual mechanism, clinical studies show patients may lose 20% or more of their body weight, making Zepbound one of the most powerful options available today
Injection technique matters With compounded tirzepatide from Priority Meds or any provider, you are typically administering the injection yourself
The trials reported minimal injection site issues, with no concerning patterns of local inflammation, infection, or tissue damage
If you experience significant digestive symptoms during dose increases, discuss with your GP or diabetes specialist nurse whether temporarily maintaining your current dose might be appropriate before escalating further